ACET Q1 2020 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$71M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-27.8% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$8M-377.9% margin

Net Income

-$4M-224.3% margin

EPS (Diluted)

$-3.84

QoQ Revenue Growth

+1.6%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$9M

Stock-Based Comp.

$299,000

Balance Sheet

Total Assets

$78M

Total Liabilities

$3M

Stockholders' Equity

$76M

Cash & Equivalents

$61M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$3M	-27.8%
Gross Profit	$2M	$3M	-27.8%
Operating Income	-$8M	-$4M	-72.9%
Net Income	-$4M	-$4M	-8.6%